BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 3171402)

  • 1. Studies on the vasoocclusive crisis of sickle cell disease IV. Mechanism of action of pentoxifylline (Trental).
    Ambrus JL; Meky N; Stadler S; Sills RH; Gastpar H; Raposa T
    J Med; 1988; 19(2):67-88. PubMed ID: 3171402
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Studies on the vasoocclusive crisis of sickle cell disease. III. In vitro and in vivo effect of the pyrimido-pyrimidine derivative, RA-233: studies on its mechanism of action.
    Ambrus JL; Bannerman RM; Sills RH; Meky N; Sharma S; Stadler S; Gastpar H; Marton J; Melewski DJ
    J Med; 1987; 18(3-4):165-98. PubMed ID: 3480932
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Studies on the management and prevention of vasoocclusive crisis in sickle cell disease.
    Ambrus JL; Ambrus CM; Bannerman R; Sills RH; Meky NN
    J Med; 1984; 15(5-6):385-407. PubMed ID: 6100377
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Studies on vasoocclusive crisis of sickle cell disease. I. Effect of pentoxifylline.
    Ambrus JL; Ambrus CM; Gastpar H; Bannerman R; Bettigole R; Friedman S
    J Med; 1979; 10(6):445-56. PubMed ID: 299453
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Amelioration of blood viscosity in sickle cell anemia by pentoxifylline. A case report.
    Keller F; Leonhardt H
    J Med; 1979; 10(6):429-33. PubMed ID: 299452
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pentoxifylline (Trental) has no significant effect on laboratory parameters in sickle cell disease.
    Billett HH; Kaul DK; Connel MM; Fabry ME; Nagel RL
    Nouv Rev Fr Hematol (1978); 1989; 31(6):403-7. PubMed ID: 2694097
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Effectiveness of treatment during osteoarticular pain crises in drepanocytosis; based on the example of pentoxifylline].
    Pichard E; Duflo B; Coulibaly S; Mariko B; Monsempes JL; Traore HA; Diallo AD
    Bull Soc Pathol Exot Filiales; 1987; 80(5):834-40. PubMed ID: 3450443
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Treatment of vaso-occlusive crisis of sickle-cell disease with pentoxifylline].
    Clerc M; Doh-Egueli D; Chapuis F; Durin A; Bertrand Y; Souillet G; Philippe N
    Pediatrie; 1989; 44(7):577-81. PubMed ID: 2812975
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A controlled trial of pentoxifylline (Trental 400) in intermittent claudication: clinical, haemostatic and rheological effects.
    Reilly DT; Quinton DN; Barrie WW
    N Z Med J; 1987 Jul; 100(828):445-7. PubMed ID: 3330188
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of pentoxifylline and metabolite on red blood cell deformability as measured by ektacytometry.
    Cummings DM; Ballas SK
    Angiology; 1990 Feb; 41(2):118-23. PubMed ID: 2306004
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Placebo controlled double-blind study of pentoxifylline in sickle cell disease patients.
    Manrique RV
    J Med; 1987; 18(5-6):277-91. PubMed ID: 3333162
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Influence of pH on the rheologic and antisickling effects of dimethyl adipimidate.
    Pennathur-Das R; Lande WM; Mentzer WC; Mohandas N; Preisler H; Kleman KM; Heath RH; Lubin BH
    J Lab Clin Med; 1984 Nov; 104(5):718-29. PubMed ID: 6491469
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Some haemorheological factors in patients with arteriosclerosis obliterans after treatment of trental.
    Chyzy R; Lukjan H; Rość D; Bielawiec M; Sawicka J
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1987; 114(4):549-54. PubMed ID: 2446996
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Improvement of blood viscosity in sickle-cell anaemia by pentoxifylline (author's transl)].
    Keller F; Leonhardt H
    Dtsch Med Wochenschr; 1980 Jun; 105(25):898-900. PubMed ID: 7408665
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of carbon dioxide and pH variations in vitro on blood respiratory functions, red blood cell volume, transmembrane pH gradients, and sickling in sickle cell anemia.
    Ueda Y; Bookchin RM
    J Lab Clin Med; 1984 Aug; 104(2):146-59. PubMed ID: 6431043
    [TBL] [Abstract][Full Text] [Related]  

  • 16. On the influence of pentoxifylline on the permeability of rat erythrocytes for methyl-O-glucose.
    Stefanovich V; Porsche E; Müller E
    Arzneimittelforschung; 1979; 29(5):757-60. PubMed ID: 582974
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of haemorheological factors in the ageing brain: long-term therapy with pentoxifylline ('Trental' 400) in elderly patients with initial mental deterioration.
    Parnetti L; Ciuffetti G; Mercuri M; Lupattelli G; Senin U
    Pharmatherapeutica; 1986; 4(10):617-27. PubMed ID: 3602014
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Haemorheological treatment of painful sickle cell crises. Use of pentoxifylline.
    Poflee VW; Gupta OP; Jain AP; Jajoo UN
    J Assoc Physicians India; 1991 Aug; 39(8):608-9. PubMed ID: 1814876
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Monovalent cation changes in sickle erythrocytes: a direct reflection of alpha-globin gene number.
    Embury SH; Backer K; Glader BE
    J Lab Clin Med; 1985 Jul; 106(1):75-9. PubMed ID: 4009025
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oxpentifylline and cetiedil citrate improve deformability of dehydrated sickle cells.
    Stuart J; Stone PC; Bilto YY; Keidan AJ
    J Clin Pathol; 1987 Oct; 40(10):1182-6. PubMed ID: 3119675
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.